A double-blind, placebo-managed research made use of intravenous allogeneic human MSCs in fifty three put up-MI people, with comparable adverse events concerning equally teams. Ambulatory EKG confirmed minimized episodes of ventricular tachycardia, together with enhanced compelled expiratory volume